Geneos Wealth Management Inc.
Position in PLX — Protalix BioTherapeutics, Inc.
CIK 1764754
ENGLEWOOD, CO
Position in PLX
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$1,864
-$1,456 QoQ
Shares Held
800
-60.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#84
of 101 holders
Holding Since
Sep 2023
2 quarters on record
Common Shares in PLX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Geneos Wealth Management Inc. holds $2,753,792 across 36 Biotechnology names. PLX ranks #27 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GALT |
Galectin Therapeutics Inc
|
240,427 | $1,115,581 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
|
12,199 | $954,815 | |
| 3 | AVXL |
Anavex Life Sciences Corp.
|
48,100 | $124,579 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
137 | $85,424 | |
| 5 | TGTX |
Tg Therapeutics, Inc.
|
1,269 | $69,718 | |
| 6 | IBRX |
ImmunityBio, Inc.
|
5,754 | $50,376 | |
| 7 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
101 | $50,169 | |
| 8 | INSM |
INSMED Inc
|
414 | $44,140 |
All Filings in PLX
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,864 | 800 | Shares | Sole | 2026-08-06 | |
| 2023-09-30 | $3,320 | 2,000 | Shares | Sole | 2023-10-11 | |
| No filing history on record for this holder in this stock. | ||||||